We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Regions Financial
RF
$26.9B
| $46.2M | 0.24% |
2,300,570
-6,450
| -0.3% | -$136K |
|
102
Truist Financial
TFC
$64.3B
| $45.4M | 0.24% |
1,043,828
-69,313
| -6% | -$3.33M |
|
103
Zoetis
ZTS
$30.4B
| $45.1M | 0.23% |
303,908
+48,003
| +19% | +$8.02M |
|
104
American Express
AXP
$232B
| $45M | 0.23% |
333,704
+46,245
| +16% | +$7M |
|
105
Yum! Brands
YUM
$41B
| $44.7M | 0.23% |
420,461
-248,012
| -37% | -$28.8M |
|
106
Gen Digital
GEN
$17.1B
| $44.3M | 0.23% |
2,197,435
+1,657,640
| +307% | +$38.3M |
|
|
GTM
107
ZoomInfo Technologies
GTM
$1.12B
| $43.5M | 0.23% |
1,045,339
+894,415
| +593% | +$38M |
|
108
Owens Corning
OC
$12.3B
| $43.2M | 0.22% |
549,654
-20,684
| -4% | -$1.74M |
|
109
W.W. Grainger
GWW
$61.5B
| $42.3M | 0.22% |
86,465
+2,013
| +2% | +$1.06M |
|
110
Globe Life
GL
$13.8B
| $41.7M | 0.22% |
+417,848
| New | +$41.9M |
|
111
Jabil
JBL
$38.4B
| $41.1M | 0.21% |
711,953
-1,089,642
| -60% | -$63.4M |
|
112
Biogen
BIIB
$30.9B
| $40.6M | 0.21% |
152,168
+111,159
| +271% | +$23.6M |
|
113
Simon Property Group
SPG
$71.4B
| $40.6M | 0.21% |
452,302
+118,699
| +36% | +$12.1M |
|
114
Corpay
CPAY
$26.9B
| $40.3M | 0.21% |
228,706
+131,370
| +135% | +$28.2M |
|
115
Valero Energy
VLO
$95.1B
| $40.2M | 0.21% |
376,690
-2,342
| -0.6% | -$258K |
|
116
Cadence Design Systems
CDNS
$89B
| $40.2M | 0.21% |
246,135
+182,821
| +289% | +$31.4M |
|
117
Philip Morris
PM
$290B
| $40.2M | 0.21% |
484,132
+53,960
| +13% | +$5.15M |
|
118
NRG Energy
NRG
$25.4B
| $39.9M | 0.21% |
1,042,151
-228,108
| -18% | -$9.1M |
|
119
Elevance Health
ELV
$86.5B
| $39.5M | 0.2% |
86,852
-2,805
| -3% | -$1.34M |
|
120
Datadog
DDOG
$86.5B
| $38.9M | 0.2% |
438,168
-26,404
| -6% | -$2.66M |
|
121
Consolidated Edison
ED
$39.8B
| $38.7M | 0.2% |
451,346
-2,223
| -0.5% | -$214K |
|
122
Gartner
IT
$11.3B
| $37.6M | 0.2% |
136,043
+316
| +0.2% | +$88.6K |
|
123
Mid-America Apartment Communities
MAA
$15.4B
| $37.5M | 0.19% |
241,783
+202,302
| +512% | +$34.8M |
|
124
Regeneron Pharmaceuticals
REGN
$82.1B
| $37.2M | 0.19% |
54,059
-3,260
| -6% | -$2.05M |
|
125
Vail Resorts
MTN
$5.29B
| $37.1M | 0.19% |
+172,154
| New | +$39.1M |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.